Cargando…
The Utility of Circulating and Imaging Biomarkers Alone and in Combination in Heart Failure
Clinical trials in the treatment of heart failure have relied on the use of a composite of hard clinical endpoints to evaluate the efficacy of the treatment arm. This has led to prolonged trials requiring large patient cohorts and extensive funding to reach statistical significance. In this paper, w...
Autores principales: | Jaltotage, Biyanka, Dwivedi, Girish, Ooi, Daryl Eng Lee, Mahadavan, Gnanadevan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950455/ https://www.ncbi.nlm.nih.gov/pubmed/34036914 http://dx.doi.org/10.2174/1573403X17666210525103512 |
Ejemplares similares
-
Coronary computed tomographic angiography derived findings and risk score improves the allocation of lipid lowering therapy compared to clinical score
por: Jaltotage, Biyanka, et al.
Publicado: (2022) -
Short-term DAPT after coronary stenting has similar ischemic and bleeding outcomes as long-term DAPT: a 5-year population-based cohort study
por: Balaji Srinivasan, Sriraag, et al.
Publicado: (2022) -
Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure
por: Yao, Can, et al.
Publicado: (2021) -
Multidimensional Approach of Heart Failure Diagnosis and Prognostication Utilizing Cardiac Imaging with Biomarkers
por: Kim, In-Cheol, et al.
Publicado: (2022) -
Circulating Circular RNAs: Novel Biomarkers for Heart Failure
por: Sun, Chuan, et al.
Publicado: (2020)